LEADER 03437nam 22007215 450 001 9910523787303321 005 20240429155227.0 010 $a3-030-86076-0 024 7 $a10.1007/978-3-030-86076-9 035 $a(CKB)5670000000200408 035 $a(MiAaPQ)EBC6877842 035 $a(Au-PeEL)EBL6877842 035 $a(OCoLC)1295275583 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/78275 035 $a(DE-He213)978-3-030-86076-9 035 $a(PPN)272258202 035 $a(EXLCZ)995670000000200408 100 $a20220131d2022 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPrevention and Treatment of Atherosclerosis $eImproving State-of-the-Art Management and Search for Novel Targets /$fedited by Arnold von Eckardstein, Christoph J. Binder 205 $a1st ed. 2022. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2022. 215 $a1 online resource (537 pages) 225 1 $aHandbook of Experimental Pharmacology,$x1865-0325 ;$v270 311 $a3-030-86075-2 327 $aDiet, Life Style, Smoking -- Blood Pressure Lowering -- Glycemic Control in Diabetes -- LDL-Cholesterol Lowering -- Antithrombotic Therapy (Platelet Inhibition, Anti-coagulation) -- Triglyceride Rich Lipoproteins -- HDL -- Lipoprotein(a) -- Obesity, Non-alcoholic Fatty Liver Disease, and Metabolic Syndrome -- Nutraceuticals / Functional Food -- Adipose Tissue (WAT, BAT) -- Microbiota and Cardiometabolic Disease -- SMCs, Matrix -- Immune Modulation -- NETs and Neutrophils -- Genomic Strategies Towards Identification of Novel Therapeutic Targets -- Non Coding RNAs -- Metabolomics, Lipidomics -- Epigenomics. 330 $aThis open access book is supported by the European Atherosclerosis Society Association (EAS). This follow-up edition of the well-received Handbook volume 'Atherosclerosis: Diet and Drugs' reflects the state-of-the-art and most recent developments in atherosclerosis research. Outstanding international experts give a comprehensive overview of the field covering topics, such as improving the treatment focusing on established targets, novel drug developments addressing pre-defined targets, hypothesis-based and hypothesis-free approaches to unravel novel targets. . 410 0$aHandbook of Experimental Pharmacology,$x1865-0325 ;$v270 606 $aInternal medicine 606 $aPharmacology 606 $aDiseases 606 $aInternal Medicine 606 $aPharmacology 606 $aInternal Medicine 606 $aDiseases 606 $aArterioesclerosi$2thub 606 $aTerapčutica$2thub 606 $aMedicina preventiva$2thub 608 $aLlibres electrňnics$2thub 615 0$aInternal medicine. 615 0$aPharmacology. 615 0$aDiseases. 615 14$aInternal Medicine. 615 24$aPharmacology. 615 24$aInternal Medicine. 615 24$aDiseases. 615 7$aArterioesclerosi 615 7$aTerapčutica 615 7$aMedicina preventiva 676 $a616 700 $aEckardstein$b Arnold von$01424178 701 $aBinder$b Christoph J$01214747 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910523787303321 996 $aPrevention and Treatment of Atherosclerosis$93553182 997 $aUNINA